Log In
Print
BCIQ
Print
Print this Print this
 

99mTc-MIP-1404

  Manage Alerts
Collapse Summary General Information
Company Progenics Pharmaceuticals Inc.
DescriptionTechnetium-99m-labeled small molecule targeting prostate-specific membrane antigen (PSMA)
Molecular Target Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of ActionDiagnostic
Latest Stage of DevelopmentPhase II
IndicationCancer, Diagnostic
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today